Dare Bioscience
DARE
37 hedge funds and large institutions have $58.6M invested in Dare Bioscience in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 12 increasing their positions, 3 reducing their positions, and 2 closing their positions.
700% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 2
300% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 3
61% more funds holding
Funds holding: 23 → 37 (+14)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
31% less capital invested
Capital invested by funds: $84.5M → $58.6M (-$26M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.98M |
| 2 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$1.58M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.51M |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$1.04M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$858K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
-$203K |
| 2 |
Goldman Sachs
New York
|
-$93.4K |
| 3 |
Morgan Stanley
New York
|
-$21.3K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7.55K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WS
26
Wedbush Securities
Los Angeles,
California
| $73K | +$91.3K | +133 | New |
|
27
Creative Planning
Overland Park,
Kansas
| $47K | +$59.1K | +86 | New |
|
28
Royal Bank of Canada
Toronto,
Ontario, Canada
| $22K | +$11K | +16 | +67% |
|
|
29
UBS Group
Zurich,
Switzerland
| $18K | -$7.55K | -11 | -26% |
|
|
BG
30
BlackRock Group
London,
United Kingdom
| $18K | +$22K | +32 | New |
|
|
BIM
31
BlackRock Investment Management
Wilmington,
Delaware
| $15K | +$9.61K | +14 | +108% |
|
|
BJ
32
BlackRock Japan
Tokyo,
Japan
| $14K | +$17.2K | +25 | New |
|
33
Bank of America
Charlotte,
North Carolina
| $11K | +$687 | +1 | +5% |
|
|
34
Morgan Stanley
New York
| $8K | -$21.3K | -31 | -67% |
|
|
GT
35
Glenmede Trust
Philadelphia,
Pennsylvania
| $4K | +$6.18K | +9 | New |
|
|
RFA
36
Reilly Financial Advisors
La Mesa,
California
| $1K | – | – | – |
|
37
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $1 | +$1.37K | +2 | New |
|
|
SIM
38
Spark Investment Management
New York
| – | -$203K | -189 | Closed |
|
|
TRCT
39
Tower Research Capital (TRC)
New York
| – | -$8K | -8 | Closed |
|
DARE Hedge Fund Activity: Q2 2015 in Review
37 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q2 2015, worth a combined $58.6M — down 31% from $84.5M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new DARE positions and 2 closed out — a net gain of 14 holders — while 12 added to existing stakes and 3 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $8.98M. The largest seller was Spark Investment Management, exiting entirely with an estimated $203K sold.
- 37 institutional investors held Dare Bioscience (DARE) as of Q2 2015, up from 23 in Q1 2015.
- Funds reported $58.6M of Dare Bioscience stock for Q2 2015, down 31% quarter-over-quarter.
- 16 funds opened new Dare Bioscience positions in Q2 2015 and 2 closed out, a net change of +14 holders.
- The largest Dare Bioscience buyer in Q2 2015 was Fidelity Investments, an estimated $8.98M added.
- The largest Dare Bioscience seller in Q2 2015 was Spark Investment Management, an estimated $203K sold.
Based on aggregated 13F filings for Q2 2015.